April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
November 16, 2023
The University of Cincinnati Gardner Neuroscience Institute's Brandon Foreman recently published survey results identifying areas of consensus and needs for further research to develop a standard practice for comprehensively monitoring brain health in the intensive care unit.
April 12, 2024
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
May 24, 2022
The University of Cincinnati's College of Medicine and College-Conservatory of Music collaborate on the innovative Dementia and the Arts course and intervention for community members with cognitive disorders and their family members.
April 5, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is researching how different rates of cerebral small vessel disease and genetic differences contribute to higher rates of Alzheimer's disease and related dementias in non-Hispanic Black populations compared to non-Hispanic white patients.
July 13, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is leading two research projects to learn more about the relationship between sickle cell disease, stroke and cognitive impairment.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.